Literature DB >> 1498755

Use of host factors to identify people at high risk for cutaneous malignant melanoma .

L D Marrett1, W D King, S D Walter, L From.   

Abstract

OBJECTIVE: To determine which host characteristics are risk factors for cutaneous malignant melanoma in order to aim prevention and early detection programs at people at high risk.
DESIGN: Case-control study.
SETTING: Southern Ontario.
SUBJECTS: The 583 case subjects were aged 20 to 69 years and had had malignant melanoma newly diagnosed between Oct. 1, 1984, and Sept. 30, 1986. The 608 control subjects were randomly selected from a list of residents in the study area and were stratum matched for age, sex and municipality. INTERVENTION: Through in-person interviews the interviewer ascertained exposure to putative external risk factors and assessed skin colour and number of nevi on the arm, and the subject reported his or her natural hair colour at age 20 years, eye colour, skin reaction to repeated sun exposure, and freckle and whole-body nevus densities.
RESULTS: Although all the host factors mentioned were significantly associated with melanoma risk when considered separately, only hair colour, skin reaction to repeated sun exposure, and self-reported freckle and nevus densities remained significant after backward logistic regression analysis. The odds ratio for melanoma was estimated to be 10.7 in people who had many nevi compared with those who had none (95% confidence interval [CI] 6.6 to 17.4), 4.0 in people who had red hair compared with those who had black hair (95% CI 1.9 to 8.2), 1.9 in people who had many freckles compared with those who had none or few (95% CI 1.3 to 2.8) and 1.4 respectively in people who burned and had a subsequent increase in tan and those who burned and had no increase in tan after repeated sun exposure compared with those who did not burn [corrected].
CONCLUSIONS: Four risk factors for malignant melanoma have been identified. Prospective evaluation of their predictive value should be done. In the meantime, however, these factors should be used to identify people apparently at high risk for malignant melanoma, who can then be targeted for early detection and prevention programs.

Entities:  

Mesh:

Year:  1992        PMID: 1498755      PMCID: PMC1336243     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  20 in total

1.  The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps.

Authors:  S D Walter; L D Marrett; L From; C Hertzman; H S Shannon; P Roy
Journal:  Am J Epidemiol       Date:  1990-02       Impact factor: 4.897

2.  Personal risk-factor chart for cutaneous melanoma.

Authors:  R M MacKie; T Freudenberger; T C Aitchison
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

3.  Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations.

Authors:  N Dubin; M Moseson; B S Pasternack
Journal:  Recent Results Cancer Res       Date:  1986

4.  Trends in malignant melanoma of the skin.

Authors:  O M Jensen; A M Bolander
Journal:  World Health Stat Q       Date:  1980

5.  Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn.

Authors:  J M Elwood; S M Whitehead; J Davison; M Stewart; M Galt
Journal:  Int J Epidemiol       Date:  1990-12       Impact factor: 7.196

6.  Malignant melanoma in Scotland 1979-1983.

Authors:  R M MacKie; J F Smyth; D S Soutar; K C Calman; A C Watson; J A Hunter; K M McLaren; J B MacGillivray; J L McPhie; R Rankin
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

7.  Common acquired naevi and the risk of malignant melanoma.

Authors:  A Green; R MacLennan; V Siskind
Journal:  Int J Cancer       Date:  1985-03-15       Impact factor: 7.396

8.  Observer perception of skin color in a study of malignant melanoma.

Authors:  C Hertzman; S D Walter; L From; A Alison
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

9.  The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors.

Authors:  A Osterlind; M A Tucker; K Hou-Jensen; B J Stone; G Engholm; O M Jensen
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

10.  Aetiological factors in cutaneous malignant melanomas seen at a UK skin clinic.

Authors:  C M Bell; C M Jenkinson; T J Murrells; R G Skeet; J D Everall
Journal:  J Epidemiol Community Health       Date:  1987-12       Impact factor: 3.710

View more
  16 in total

1.  Nevi and migration within the United States and Canada: a population-based cross-sectional study.

Authors:  L K Dennis; E White; B McKnight; A Kristal; J A Lee; P Odland
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

2.  Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Authors:  Nicholas J Taylor; Nancy E Thomas; Hoda Anton-Culver; Bruce K Armstrong; Colin B Begg; Klaus J Busam; Anne E Cust; Terence Dwyer; Lynn From; Richard P Gallagher; Stephen B Gruber; Diane E Nishri; Irene Orlow; Stefano Rosso; Alison J Venn; Roberto Zanetti; Marianne Berwick; Peter A Kanetsky
Journal:  Int J Cancer       Date:  2016-05-30       Impact factor: 7.396

Review 3.  Predicting melanoma risk: theory, practice and future challenges.

Authors:  David Whiteman
Journal:  Melanoma Manag       Date:  2014-12-04

4.  Risk factors for growth and metastasis of small choroidal melanocytic lesions.

Authors:  C L Shields; J A Shields; H Kiratli; P De Potter; J R Cater
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Identifying risk factors using a skin cancer screening program.

Authors:  Jeremy R Etzkorn; Rajiv P Parikh; Suroosh S Marzban; Kimberly Law; Ashley H Davis; Bhupendra Rawal; Michael J Schell; Vernon K Sondak; Jane L Messina; Lois E Rendina; Jonathan S Zager; Mary H Lien
Journal:  Cancer Control       Date:  2013-10       Impact factor: 3.302

6.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

7.  Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.

Authors:  Lisa H Williams; Andrew R Shors; William E Barlow; Cam Solomon; Emily White
Journal:  J Clin Exp Dermatol Res       Date:  2011

8.  Independent validation of six melanoma risk prediction models.

Authors:  Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  J Invest Dermatol       Date:  2014-12-30       Impact factor: 8.551

Review 9.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

10.  A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Authors:  Yu-mei Chang; Julia A Newton-Bishop; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adèle C Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus-Ernstoff; Michael S Zens; Andreas Ziegler; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.